Financial Data and Key Metrics Changes - Consolidated gross profit for Q3 2025 was $19.4 million, an increase of 8.8% compared to Q3 2024 [13] - Adjusted EBITDA for Q3 2025 was $5.5 million, slightly down by 1.4% from $5.6 million in Q3 2024 [13] - Adjusted EPS remained stable at $0.42 for both Q3 2025 and Q3 2024 [13] Business Line Data and Key Metrics Changes - In healthcare, gross profit for Q3 2025 was $9.0 million, up 8.5% from $8.3 million in Q3 2024, with school revenue growing 20.7% to $24.4 million [13][14] - Engineering gross profit for Q3 2025 reached $6.9 million, a 17.3% increase from $5.9 million in Q3 2024, marking the best engineering gross profit quarter in company history [15] - IT, life sciences, and data solutions group gross profit for Q3 2025 was $3.5 million, down 4.2% from $3.7 million in Q3 2024 [16] Market Data and Key Metrics Changes - The company reported a record engineering backlog for 2026, exceeding $70 million, compared to $21 million for 2025 at the same time last year [15] - Billable hours for the first four weeks of October 2025 increased by 18% compared to the same period in 2024, indicating strong momentum heading into Q4 [15] Company Strategy and Development Direction - The company is focusing on expanding its healthcare services and enhancing its brand awareness, which has led to increased traction and a stronger talent pool [2][3] - In life sciences, the company is capitalizing on industry shifts by partnering with AI-driven companies to streamline compliance and reduce turnaround times [5] - The engineering segment is emphasizing its integrated model and strategic partnerships to enhance procurement agility and mitigate resource bottlenecks [9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about Q4 2025, expecting it to yield the highest quarterly gross profit and adjusted EBITDA of the fiscal year [17] - The company anticipates continued growth in the aerospace and defense sectors, with many programs still in their infancy [12] - Management acknowledged challenges with medical costs but indicated that measures are being taken to address these long-term [20][44] Other Important Information - The company experienced excess medical costs of approximately $1.8 million year-to-date, with Q3 particularly impacted [3] - SG&A expenses included $800,000 in medical claims over budget for Q3 alone [16] Q&A Session Summary Question: Impact of foreign candidates in the healthcare group - Management indicated that they have a pipeline of at least 300 nurses ready to come over if visa issues are resolved, with potential for 50-60 nurses in the near term [18][19] Question: Predictability of excess medical costs - Management suggested that the current level of excess medical costs is likely to continue into Q4, with long-term measures being implemented to reduce these costs [20] Question: Performance of the industrial process segment - Management noted that while the industrial process segment is stable, it requires a different trajectory for growth, with potential upside expected in 2026 [25][27] Question: Growth opportunities in energy services - Management confirmed that energy services are a significant growth area, focusing on tier-one utility clients and exploring new partnerships [30][32] Question: Capital allocation and share buyback program - Management discussed the balance between available debt and the share buyback program, emphasizing the undervaluation of their stock and the potential for future dividends [56][58]

分组1 - RCM Technologies, Inc. reported quarterly earnings of $0.42 per share, missing the Zacks Consensus Estimate of $0.45 per share, and showing a decrease from $0.44 per share a year ago, resulting in an earnings surprise of -6.67% [1] - The company posted revenues of $70.29 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.97%, and an increase from $60.37 million year-over-year [2] - Over the last four quarters, RCM Technologies has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] 分组2 - The stock has added about 4.1% since the beginning of the year, underperforming compared to the S&P 500's gain of 15.1% [3] - The current consensus EPS estimate for the coming quarter is $0.61 on $83 million in revenues, and for the current fiscal year, it is $2.38 on $313.91 million in revenues [7] - The Zacks Industry Rank indicates that the Staffing Firms industry is currently in the bottom 15% of over 250 Zacks industries, which may impact stock performance [8]

Revenue Performance - RCM Technologies reported revenue of $70.3 million for the thirteen weeks ended September 27, 2025, a 16.4% increase from $60.4 million in the prior year[3] - For the thirty-nine weeks ended September 27, 2025, revenue was $232.9 million, a 15.6% increase from $201.5 million in the prior year[4] - Consolidated revenue for the thirteen weeks ended September 27, 2025, was $70,289,000, an increase from $60,365,000 in the same period last year, representing a growth of 16.0%[19] - For the thirty-nine weeks ended September 27, 2025, consolidated revenue reached $232,928,000, up from $201,468,000 in the prior year, reflecting an increase of 15.6%[19] Profitability - Gross profit for the current quarter was $19.4 million, reflecting an 8.8% increase compared to $17.8 million in the comparable prior quarter[3] - The gross profit for the thirty-nine weeks ended September 27, 2025, was $63,665,000, an increase from $58,209,000 in the prior year, marking a growth of 9.4%[19] - GAAP net income for the current quarter was $2.3 million, or $0.30 per diluted share, down from $2.7 million, or $0.35 per diluted share, in the prior year[3] - The net income for the thirteen weeks ended September 27, 2025, was $2,259,000, a decrease from $2,746,000 in the same period last year, showing a decline of 17.7%[23] - Adjusted net income per diluted share for the current period was $1.73, an increase of 12.3% from $1.54 in the prior year[4] Expenses and Cash Flow - Selling, general and administrative expenses for the current quarter were $14.9 million, compared to $13.0 million in the prior year[11] - The company reported a net cash used in operating activities of $1,262,000 for the thirteen weeks ended September 27, 2025, compared to $4,344,000 in the same period last year, indicating an improvement in cash flow[23] Balance Sheet - Total current assets as of September 27, 2025, were $94,927,000, slightly down from $97,038,000 at December 28, 2024[21] - Total liabilities decreased to $88,437,000 as of September 27, 2025, compared to $98,593,000 at December 28, 2024, a reduction of 10.3%[21] - Cash and cash equivalents decreased to $1,309,000 as of September 27, 2025, from $4,729,000 at December 28, 2024, representing a decline of 72.3%[21] - The company’s total stockholders' equity increased to $41,378,000 as of September 27, 2025, from $33,484,000 at December 28, 2024, reflecting a growth of 23.5%[21] Future Outlook - RCM Technologies expects the fourth quarter to yield the highest quarterly gross profit and adjusted EBITDA in fiscal 2025[5] - The company experienced adjusted EBITDA of $5.5 million for the current quarter, slightly down from $5.6 million in the prior year[3] - The company anticipates continued growth in its healthcare segment, contributing to overall operational performance[5] - The company reported a record engineering backlog as of the end of October 2025, indicating strong momentum heading into 2026[5]

Core Viewpoint - RCM Technologies, Inc. has experienced a decline in stock price and is underperforming compared to broader market indices, with upcoming earnings expected to show modest growth in both earnings per share and revenue [1][2][3]. Company Performance - The stock price of RCM Technologies, Inc. closed at $22.42, reflecting a decrease of 3.74% from the previous day, while the S&P 500 gained 0.53% [1]. - Over the past month, the company's shares have decreased by 15.28%, significantly underperforming the Business Services sector, which saw a loss of 4.93% [1]. Earnings Expectations - Analysts anticipate that RCM Technologies, Inc. will report earnings of $0.45 per share, representing a year-over-year growth of 2.27% [2]. - The consensus estimate for revenue is projected at $68.26 million, indicating a 13.07% increase compared to the same quarter last year [2]. Full Year Projections - For the full year, analysts expect earnings of $2.38 per share and revenue of $313.91 million, reflecting increases of 17.24% and 12.76%, respectively, from the previous year [3]. Analyst Forecast Revisions - Recent revisions to analyst forecasts for RCM Technologies, Inc. are important as they indicate changing business trends, with positive revisions suggesting increased confidence in the company's performance [4]. Valuation Metrics - RCM Technologies, Inc. is currently trading at a Forward P/E ratio of 9.79, which is lower than the industry average Forward P/E of 16.35, indicating a potential valuation discount [7]. - The Staffing Firms industry, part of the Business Services sector, ranks in the bottom 21% of all industries according to the Zacks Industry Rank [7].

Core Insights - Wall Street analysts' recommendations significantly influence investor decisions regarding RCM Technologies, Inc. (RCMT) stock, with an average brokerage recommendation (ABR) of 1.67 indicating a preference for buying the stock [1][2][5] Brokerage Recommendations - The current ABR of 1.67 is derived from three brokerage firms, with two recommendations classified as Strong Buy, accounting for 66.7% of the total recommendations [2] - Despite the positive ABR, reliance solely on brokerage recommendations may not be advisable, as studies indicate they often fail to guide investors effectively towards stocks with high price appreciation potential [5][10] Analyst Bias and Reliability - Brokerage analysts tend to exhibit a positive bias in their ratings due to vested interests, with a ratio of five Strong Buy recommendations for every Strong Sell [6][10] - This misalignment of interests suggests that brokerage recommendations may not provide reliable insights into future stock price movements [7][10] Zacks Rank vs. ABR - The Zacks Rank, a proprietary stock rating tool, is presented in whole numbers and is based on earnings estimate revisions, which correlate strongly with near-term stock price movements [8][11] - Unlike the ABR, which may not be up-to-date, the Zacks Rank reflects timely changes in earnings estimates, making it a more reliable predictor of future stock performance [12] Current Earnings Estimates for RCMT - The Zacks Consensus Estimate for RCM Technologies remains unchanged at $2.38, indicating steady analyst views on the company's earnings prospects [13] - The unchanged consensus estimate has resulted in a Zacks Rank of 3 (Hold) for RCM Technologies, suggesting caution despite the Buy-equivalent ABR [14]

Core Viewpoint - The article discusses the reliability of Wall Street analysts' recommendations, particularly focusing on RCM Technologies, Inc. (RCMT), and emphasizes the importance of using these recommendations in conjunction with other analytical tools like Zacks Rank to make informed investment decisions [1][5]. Group 1: Brokerage Recommendations - RCM Technologies has an average brokerage recommendation (ABR) of 1.67, indicating a consensus between Strong Buy and Buy, with 66.7% of the recommendations being Strong Buy from three brokerage firms [2]. - Despite the positive ABR, it is cautioned that investors should not rely solely on this information for investment decisions, as studies show limited success of brokerage recommendations in predicting stock price increases [5][10]. Group 2: Analyst Bias and Zacks Rank - Brokerage analysts tend to exhibit a strong positive bias in their ratings due to vested interests, with five "Strong Buy" recommendations for every "Strong Sell" recommendation [6][10]. - Zacks Rank, a proprietary stock rating tool, categorizes stocks into five groups based on earnings estimate revisions, which have shown a strong correlation with near-term stock price movements, making it a more reliable indicator than ABR [8][11]. Group 3: Current Earnings Estimates and Zacks Rank for RCMT - The Zacks Consensus Estimate for RCM Technologies has remained unchanged at $2.38 over the past month, suggesting steady analyst views on the company's earnings prospects [14]. - The unchanged consensus estimate has resulted in a Zacks Rank of 3 (Hold) for RCM Technologies, indicating a cautious approach despite the Buy-equivalent ABR [15].

Company Performance - RCM Technologies, Inc. (RCMT) closed at $27.26, with a +1.34% change from the previous day, outperforming the S&P 500's daily loss of 0.05% [1] - Over the past month, shares of RCM Technologies gained 8.86%, surpassing the Business Services sector's gain of 3.12% and the S&P 500's gain of 3.44% [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of $0.45, reflecting a 2.27% increase from the prior-year quarter, with projected revenue of $68.26 million, a 13.07% rise from the same quarter last year [2] - Full-year Zacks Consensus Estimates predict earnings of $2.38 per share and revenue of $313.91 million, indicating year-over-year changes of +17.24% and +12.76%, respectively [3] Analyst Estimates and Stock Performance - Recent revisions in analyst estimates are crucial as they correlate with stock price performance, with positive changes indicating a favorable outlook on business health and profitability [4][3] - The Zacks Rank system, which assesses estimate changes, currently ranks RCM Technologies at 3 (Hold), with the Zacks Consensus EPS estimate remaining stagnant over the past month [5] Valuation Metrics - RCM Technologies is trading with a Forward P/E ratio of 11.3, which is a discount compared to the industry average Forward P/E of 16.97 [6] - The Staffing Firms industry, part of the Business Services sector, holds a Zacks Industry Rank of 204, placing it in the bottom 18% of over 250 industries [6][7]

Core Viewpoint - The article discusses the reliability of Wall Street analysts' recommendations, particularly focusing on RCM Technologies, Inc. (RCMT), and emphasizes the importance of using these recommendations in conjunction with other research tools like the Zacks Rank [1][5]. Summary by Sections Brokerage Recommendations - RCM Technologies has an average brokerage recommendation (ABR) of 1.67, indicating a consensus between Strong Buy and Buy, based on three brokerage firms' recommendations [2]. - Out of the three recommendations, two are classified as Strong Buy, accounting for 66.7% of the total recommendations [2]. Limitations of Brokerage Recommendations - Sole reliance on brokerage recommendations for investment decisions may not be wise, as studies indicate limited success in guiding investors towards stocks with the highest price increase potential [5]. - Analysts from brokerage firms often exhibit a strong positive bias in their ratings due to vested interests, with five "Strong Buy" recommendations for every "Strong Sell" [6][10]. Zacks Rank vs. ABR - The Zacks Rank is a proprietary stock rating tool that classifies stocks into five groups based on earnings estimate revisions, providing a more reliable indicator of near-term price performance compared to ABR [8][11]. - The Zacks Rank is updated more frequently and reflects changes in earnings estimates, making it a timely indicator of future price movements [13]. Current Earnings Estimates for RCM Technologies - The Zacks Consensus Estimate for RCM Technologies remains unchanged at $2.2 for the current year, suggesting steady analyst views on the company's earnings prospects [14]. - The Zacks Rank for RCM Technologies is currently 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [15].

Core Insights - Everyday People Financial Corp. reported a 40% year-over-year revenue growth in Q2 2025, reaching $22.1 million compared to $15.8 million in Q2 2024, driven by the expansion of its Revenue Cycle Management (RCM) segment and a strategic shift in its EP Homes program [2][4][7] - The company achieved a 30% increase in six-month revenues, totaling $39.8 million, reflecting strong operational performance and disciplined execution of its capital-light business strategy [2][7] - The integration of the acquisition of Commercial Collection Services Limited (CCS) into the RCM platform has contributed significantly to revenue growth, alongside organic client growth [3][7] Financial Performance - Q2 2025 net income was $0.8 million, up from $0.1 million in Q2 2024, while net income for the first half of 2025 reached $1.6 million, compared to $0.9 million for the same period in 2024 [7] - Operating cash flow for the first half of 2025 was $6.2 million, a significant increase from $2.3 million in the same period of 2024 [5] - Adjusted EBITDA for Q2 2025 was $2.2 million, slightly down from $2.4 million in Q2 2024, while for the six months ended June 30, 2025, it was $4.3 million compared to $5.5 million for the same period in 2024 [8][9] Balance Sheet Strength - Total assets increased to $73.0 million as of June 30, 2025, up from $63.9 million at the end of 2024, indicating improved financial stability [7] - Shareholders' equity more than doubled to $16.1 million from $6.3 million at the end of 2024, reflecting strong capital retention and growth [7] - Adjusted Net Working Capital deficiency improved to $1.9 million as of June 30, 2025, from $8.6 million at the end of 2024, showcasing enhanced liquidity management [11] Strategic Outlook - The company is focused on advancing its capital-light business model and executing a disciplined acquisition strategy, positioning itself for sustained growth in the latter half of 2025 and beyond [3][12] - Everyday People aims to enhance client and consumer services through innovative financial products and literacy programs, reinforcing its commitment to helping individuals and businesses manage money better [12][15]

[Financial Performance Highlights](index=1&type=section&id=Financial%20Performance%20Highlights) RCM Technologies achieved robust revenue growth and enhanced adjusted profitability in Q2 and H1 2025 [Second Quarter 2025 Performance](index=1&type=section&id=Second%20Quarter%202025%20Performance) RCM Technologies reported a 13.0% year-over-year increase in revenue to $78.2 million for the second quarter of 2025. While GAAP net income remained flat at $3.8 million, adjusted net income per diluted share grew by a strong 21.1% to $0.69, reflecting improved underlying operational profitability Q2 2025 vs Q2 2024 Key Financial Metrics | Metric | Q2 2025 (Thirteen weeks ended June 28, 2025) | Q2 2024 (Thirteen weeks ended June 29, 2024) | Change | | :--- | :--- | :--- | :--- | | **Revenue** | $78.2 million | $69.2 million | +13.0% | | **Gross Profit** | $22.3 million | $20.0 million | +11.4% | | **GAAP Net Income** | $3.8 million | $3.8 million | 0.0% | | **GAAP Diluted EPS** | $0.50 | $0.47 | +6.4% | | **Adjusted EBITDA (Non-GAAP)** | $8.1 million | $7.2 million | +12.5% | | **Adjusted Diluted EPS (Non-GAAP)** | $0.69 | $0.57 | +21.1% | [Year-to-Date 2025 Performance](index=1&type=section&id=Year-to-Date%202025%20Performance) For the first half of 2025, revenue increased by 15.3% to $162.6 million compared to the same period in 2024. This top-line growth translated to an 18.9% increase in adjusted net income per diluted share, which reached $1.32 H1 2025 vs H1 2024 Key Financial Metrics | Metric | H1 2025 (Twenty-six weeks ended June 28, 2025) | H1 2024 (Twenty-six weeks ended June 29, 2024) | Change | | :--- | :--- | :--- | :--- | | **Revenue** | $162.6 million | $141.1 million | +15.3% | | **Gross Profit** | $44.3 million | $40.4 million | +9.6% | | **GAAP Net Income** | $8.0 million | $7.7 million | +3.9% | | **GAAP Diluted EPS** | $1.04 | $0.95 | +9.5% | | **Adjusted EBITDA (Non-GAAP)** | $15.9 million | $14.0 million | +13.6% | | **Adjusted Diluted EPS (Non-GAAP)** | $1.32 | $1.11 | +18.9% | [Management Commentary](index=1&type=section&id=Management%20Commentary) Management expressed a positive outlook, highlighting consistent growth across all business segments during the second quarter. They specifically pointed to growing momentum in the Engineering division and are anticipating a strong second half of the year - Executive Chairman Bradley Vizi emphasized the resilience of the business model, citing consistent growth across all three segments and building towards an expected strong second half of the year[5](index=5&type=chunk) - CFO Kevin Miller noted that momentum within the Engineering segment continues to build, suggesting the company is unlocking the next phase of growth in that business[5](index=5&type=chunk) [Consolidated Financial Statements](index=3&type=section&id=Consolidated%20Financial%20Statements) Consolidated statements for Q2 and H1 2025 show revenue growth, increased operating expenses, and shifts in cash flow [Statements of Operations](index=3&type=section&id=Statements%20of%20Operations) The consolidated statements of operations detail a year-over-year revenue increase for both the second quarter and first half of 2025. However, growth in operating income was tempered by higher cost of services and a significant rise in Selling, General and Administrative (SG&A) expenses, which grew by 12.8% in the second quarter Q2 Income Statement Highlights (in thousands) | Account | Q2 2025 | Q2 2024 | % Change | | :--- | :--- | :--- | :--- | | Revenue | $78,166 | $69,164 | 13.0% | | Gross Profit | $22,277 | $20,001 | 11.4% | | SG&A | $15,275 | $13,545 | 12.8% | | Operating Income | $6,601 | $5,819 | 13.4% | | Net Income | $3,785 | $3,762 | 0.6% | H1 Income Statement Highlights (in thousands) | Account | H1 2025 | H1 2024 | % Change | | :--- | :--- | :--- | :--- | | Revenue | $162,639 | $141,103 | 15.3% | | Gross Profit | $44,255 | $40,368 | 9.6% | | Operating Income | $13,184 | $11,655 | 13.1% | | Net Income | $7,971 | $7,714 | 3.3% | [Balance Sheets](index=7&type=section&id=Balance%20Sheets) As of June 28, 2025, the company's balance sheet strengthened, with total assets increasing to $135.6 million and total stockholders' equity rising by 12.8% to $37.8 million since year-end 2024. Key changes in current assets and liabilities include an increase in accounts receivable and a significant rise in deferred revenue, offset by a decrease in accounts payable Selected Balance Sheet Data (in thousands) | Account | June 28, 2025 | Dec 28, 2024 | % Change | | :--- | :--- | :--- | :--- | | Total Current Assets | $100,709 | $97,038 | 3.8% | | Total Assets | $135,586 | $132,077 | 2.7% | | Total Current Liabilities | $54,490 | $53,633 | 1.6% | | Borrowings under line of credit | $34,015 | $34,967 | -2.7% | | Total Stockholders' Equity | $37,786 | $33,484 | 12.8% | [Statements of Cash Flows](index=9&type=section&id=Statements%20of%20Cash%20Flows) For the first half of 2025, net cash provided by operating activities was $8.8 million, a decrease from $12.2 million in the prior-year period, primarily driven by a $15.3 million increase in accounts receivable during the second quarter. The company used $7.1 million for financing activities, largely for treasury stock repurchases, compared to $13.5 million in the first half of 2024 - In Q2 2025, the company experienced a net cash usage of **$7.9 million** from operating activities, a stark contrast to the **$5.7 million** provided by operations in Q2 2024. This was mainly due to a significant increase in accounts receivable[23](index=23&type=chunk) H1 Cash Flow Summary (in thousands) | Cash Flow Activity | H1 2025 | H1 2024 | | :--- | :--- | :--- | | Net cash provided by operating activities | $8,782 | $12,151 | | Net cash used in investing activities | ($900) | ($1,067) | | Net cash used in financing activities | ($7,092) | ($13,510) | | **Increase (decrease) in cash** | **$743** | **($2,804)** | [Segment Performance](index=6&type=section&id=Segment%20Performance) Q2 2025 segment performance shows strong revenue growth in Specialty Health Care and Engineering, with varied margin trends [Segment Revenue and Gross Profit Analysis](index=6&type=section&id=Segment%20Revenue%20and%20Gross%20Profit%20Analysis) In Q2 2025, growth was led by the Specialty Health Care and Engineering segments, with revenues increasing 15.9% and 17.8% YoY, respectively. The Life Sciences, Data and Solutions segment experienced a 9.3% revenue decline. Gross profit margins compressed slightly in the Engineering segment from 26.5% to 24.5%, while the Life Sciences, Data and Solutions segment saw margin expansion to 39.8% Q2 2025 Revenue by Segment (in thousands) | Segment | Q2 2025 Revenue | Q2 2024 Revenue | YoY Change | | :--- | :--- | :--- | :--- | | Specialty Health Care | $42,822 | $36,932 | +15.9% | | Engineering | $26,521 | $22,508 | +17.8% | | Life Sciences, Data and Solutions | $8,823 | $9,724 | -9.3% | | **Consolidated** | **$78,166** | **$69,164** | **+13.0%** | Q2 2025 Gross Profit Margin by Segment | Segment | Q2 2025 Gross Profit Margin | Q2 2024 Gross Profit Margin | Change (bps) | | :--- | :--- | :--- | :--- | | Specialty Health Care | 28.7% | 28.8% | -10 bps | | Engineering | 24.5% | 26.5% | -200 bps | | Life Sciences, Data and Solutions | 39.8% | 34.9% | +490 bps | | **Consolidated** | **28.5%** | **28.9%** | **-40 bps** | [Non-GAAP Financial Measures](index=4&type=section&id=Non-GAAP%20Financial%20Measures) Non-GAAP metrics provide a clearer view of operational performance by adjusting for non-recurring and non-cash items [Reconciliation of GAAP to Non-GAAP Results](index=4&type=section&id=Reconciliation%20of%20GAAP%20to%20Non-GAAP%20Results) The company provides non-GAAP metrics to offer a clearer view of ongoing operational performance by excluding items such as equity compensation, foreign currency transaction impacts, and potential financing costs. For Q2 2025, Adjusted EBITDA increased to $8.1 million from $7.2 million YoY. Adjusted net income grew to $5.2 million ($0.69 per diluted share) from $4.6 million ($0.57 per diluted share) in the prior-year quarter Reconciliation of GAAP Net Income to Adjusted EBITDA (in thousands) | Metric | Q2 2025 | Q2 2024 | H1 2025 | H1 2024 | | :--- | :--- | :--- | :--- | :--- | | **GAAP Net Income** | **$3,785** | **$3,762** | **$7,971** | **$7,714** | | Income tax expense | 1,887 | 1,483 | 3,586 | 2,941 | | Interest expense, net | 650 | 581 | 1,301 | 1,059 | | Depreciation & Amortization | 401 | 378 | 825 | 710 | | **EBITDA (Non-GAAP)** | **$6,723** | **$6,204** | **$13,683** | **$12,424** | | Other Adjustments* | 1,412 | 1,004 | 2,232 | 1,587 | | **Adjusted EBITDA (Non-GAAP)** | **$8,135** | **$7,208** | **$15,915** | **$14,011** | *Other Adjustments include Equity compensation, foreign currency transactions, and potential financing transactions Reconciliation of GAAP to Adjusted Diluted EPS | Metric | Q2 2025 | Q2 2024 | H1 2025 | H1 2024 | | :--- | :--- | :--- | :--- | :--- | | **GAAP Diluted EPS** | **$0.50** | **$0.47** | **$1.04** | **$0.95** | | Adjustments | $0.19 | $0.10 | $0.28 | $0.16 | | **Adjusted Diluted EPS (Non-GAAP)** | **$0.69** | **$0.57** | **$1.32** | **$1.11** |